Archives of Gynecology and Obstetrics

, Volume 282, Issue 3, pp 293–300 | Cite as

The role of lymphadenectomy in uterine leiomyosarcoma: review of the literature and recommendations for the standard surgical procedure

  • Alexandros Dafopoulos
  • Panagiotis Tsikouras
  • Marina Dimitraki
  • Georgios Galazios
  • Vasileios Liberis
  • Georgios Maroulis
  • Alexander Tobias Teichmann
Gynecologic Oncology


Uterine sarcomas are rare and aggressive gynaecologic malignancies with poor prognosis, arising from myometrial or endometrial tissue. These rare cancers can be aggressive, and account for a greatly disproportionate amount of deaths from uterine cancers. The histological uterine sarcomas classification includes carcinosarcomas (malignant mesodermal mixed tumors), accounting for 40% of cases, leiomyosarcomas (40%) and endometrial stromal sarcomas (10–15%). Each group of these tumors presents differences in diagnosis, prognostic factors, treatment, and outcome. Uterine leiomyosarcomas typically affects women in their sixth decade of life, presenting with atypical symptoms such as abnormal uterine bleeding and abdominal pain. The optimal treatment of uterine leiomyosarcomas is surgery, including total abdominal hysterectomy and bilateral salpingooophorectomy. The aim of this study was to conduct a systematic review of the literature regarding the standard surgical procedure of uterine leiomyosarcomas and investigate whether lymphadenectomy affects the 5-year DSS, as well as other relevant clinical outcomes, in women with uterine leiomyosarcomas. For this purpose, MEDLINE, EMBASE, and the Cochrane Library databases were reviewed, and a critical account of the management strategies of these tumors is presented.


Uterine sarcoma Lymphadenectomy Leiomyosarcomas 


Conflict of interest statement



  1. 1.
    Ueda SM, Cheung MK, Osann K et al (2007) Factors responsible for the increase in death rate of women diagnosed with uterine corpus cancer. In: Proceedings of the Society of Gynecologic Oncologists 38th annual meeting, Abstract 644Google Scholar
  2. 2.
    Tavassoli FA, Devilee P (2003) World Health Organization classification of tumours. In: Pathology and genetics of tumours of the breast and female genital organs. IARC Press, LyonGoogle Scholar
  3. 3.
    Benoit L, Arnould L, Cheynel N et al (2005) The role of surgery and treatment trends in uterine sarcoma. Eur J Surg Oncol 31:434–442CrossRefPubMedGoogle Scholar
  4. 4.
    Harlow BL, Weiss NS, Lofton S (1986) The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 76:399–402PubMedGoogle Scholar
  5. 5.
    El Husseiny G, Al Bareedy N, Mourad WA et al (2002) Prognostic factors and treatment modalities in uterine sarcoma. Am J Clin Oncol 25:256–260CrossRefPubMedGoogle Scholar
  6. 6.
    Pautier P, Genestie C, Rey A et al (2000) Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 88:1425–1431CrossRefPubMedGoogle Scholar
  7. 7.
    Jones MW, Norris HJ (1995) Clinicopathologic study of 28 uterine leiomyosarcomas with metastasis. Int J Gynecol Pathol 14:243–249CrossRefPubMedGoogle Scholar
  8. 8.
    Kapp D, Shin J, Chan J (2008) Prognostic factors and survival in 1396 patients with uterine lyomeiosarcomas. Emphasis on impact of lymphadenectomy and oophorectomy. Cancer 112:820–830CrossRefPubMedGoogle Scholar
  9. 9.
    Leibsohn S, d’Ablaing G, Mishell DR Jr, Schlaerth JB (1990) Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas. Am J Obstet Gynecol 162:968–976PubMedGoogle Scholar
  10. 10.
    Wilkinson N, Rollason TP (2001) Recent advances in the pathology of smooth muscle tumours of the uterus. Histopathology 39:331–341CrossRefPubMedGoogle Scholar
  11. 11.
    Zaloudek C, Norris HJ (1994) Mesenchymal tumors of the uterus. In: Kurman RJ (ed) Blaustein’s pathology of the female genital tract, 4th edn. Springer, New York, pp 487–528Google Scholar
  12. 12.
    Barter JF, Smith EB, Szpak CA, Hinshaw W, Clarke-Pearson DL, Creasman WT (1985) Leiomyosarcoma of the uterus: clinico-sarcopathologic study of 21 cases. Gynecol Oncol 21:220–227CrossRefPubMedGoogle Scholar
  13. 13.
    Schwartz LB, Diamond MP, Schwartz PE (1993) Leiomyosarcomas: clinical presentation. Am J Obstet Gynecol 168:180–183PubMedGoogle Scholar
  14. 14.
    McLeod AJ, Zornoza J, Shirkhoda A (1984) Leiomyosarcoma: computed tomographic findings. Radiology 152:133–136PubMedGoogle Scholar
  15. 15.
    Hata K, Hata T, Makihara K, Aoki S, Takamiya O, Kitao M, Harada Y, Nagaoka S (1990) Sonographic findings of uterine leiomyosarcoma. Gynecol Obstet Invest 30:242–245CrossRefPubMedGoogle Scholar
  16. 16.
    Gadducci A, Landoni F, Sartori E, Zola P, Maggino T, Lissoni A, Bazzurini L, Arisio R, Romagnolo C, Cristofani R (1996) Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol 62:25–32CrossRefPubMedGoogle Scholar
  17. 17.
    Toledo G, Oliva E (2008) Smooth muscle tumors of the uterus. A practical approach. Arch Pathol Lab Med 132:595–605PubMedGoogle Scholar
  18. 18.
    Dinh TA, Oliva EA, Fuller AF Jr, Lee H, Goodman A (2004) The treatment of uterine leiomyosarcoma: results from a 10-year experience (1990–1999) at the Massachusetts General Hospital. Gynecol Oncol 92:648–652CrossRefPubMedGoogle Scholar
  19. 19.
    Giuntoli RL II, Metzinger DS, DiMarco CS et al (2003) Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol 89:460–469CrossRefPubMedGoogle Scholar
  20. 20.
    George M, Pejovic M, Kramar A, Gynecologic Cooperating Group of French Oncology Centers (1986) Uterine sarcomas: prognostic factors and treatment modalities—study of 209 patients. Gynecol Oncol 24:58–67CrossRefPubMedGoogle Scholar
  21. 21.
    Wright JD, Seshan VE, Shan M et al (2008) The role of radiation in improving survival for early-stage carcinosarcoma and leiomyosarcoma. Am J Obstet Gynecol 199:536.e1–536.e8CrossRefGoogle Scholar
  22. 22.
    Mayerhofer K, Obermair A, Windbichler G et al (1999) Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 74:196–201CrossRefPubMedGoogle Scholar
  23. 23.
    Gadducci A, Sartori E, Landoni F, Zola P, Maggino T, Urgesi A (1996) Endometrial stroma sarcoma: analysis of treatment failures and survival. Gynecol Oncol 63:247–253CrossRefPubMedGoogle Scholar
  24. 24.
    Major FJ, Blessing JA, Silverberg SG, Morrow CP, Creasman WT, Currei JL et al (1993) Prognostic factors in early stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71:1702–1709PubMedGoogle Scholar
  25. 25.
    Yoney A, Eren B, Eskici S, Salman A, Unsal M (2008) Retrospective analysis of 105 cases with uterine sarcoma. Bull Cancer 95(3):E10–E17PubMedGoogle Scholar
  26. 26.
    Lurain J, Piver M (1992) Uterine sarcomas: clinical features and management. In: Coppleson M (ed) Gynecological oncology. Churchill Livingstone, Edinburgh, pp 827–842Google Scholar
  27. 27.
    Gadducci A, Cosio S, Romanini A, Genazzani AR (2008) The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 65(2):129–142CrossRefPubMedGoogle Scholar
  28. 28.
    International Federation of Gynecology and Obstetrics (1989) Corpus cancer staging. Int J Gynecol Obstet 28:190Google Scholar
  29. 29.
    Bell SW, Kempson RL, Hendrickson (1994) Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 18(6):535–558CrossRefPubMedGoogle Scholar
  30. 30.
    Chauveinc L, Deniaud E, Plancher C, Sastre X, Amsani F, de la Rochefordiere A, Rozemberg H, Clough KB (1999) Uterine sarcomas: the Curie Institute’s experience. Prognostic factors and adjuvant treatment. Gynecol Oncol 72:232–237CrossRefPubMedGoogle Scholar
  31. 31.
    Salazar OM, Dunne ME (1980) The role of radiation therapy in the management of uterine sarcomas. Int J Radiat Oncol Biol Phys 6:899–902PubMedGoogle Scholar
  32. 32.
    Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr (1988) Treatment of uterine leiomyosarcoma. Obstet Gynecol 71:845–850PubMedGoogle Scholar
  33. 33.
    Berchuck A, Rubin SC, Hoskins WJ, Saigo PE, Pierce VK, Lewis JL Jr (1990) Treatment of endometrial stromal tumors. Gynecol Oncol 36:60–65CrossRefPubMedGoogle Scholar
  34. 34.
    Sartori E, Bazzurini L, Gadducci A et al (1997) Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol 67:70–75CrossRefPubMedGoogle Scholar
  35. 35.
    Gadducci A, Sartori E, Landoni F et al (2002) The prognostic relevance of histological type in uterine sarcomas: a Cooperation Task Force (CTF) multivariate analysis of 249 cases. Eur J Gynaecol Oncol 23:295–299PubMedGoogle Scholar
  36. 36.
    De Fusco PA, Gaffey TA, Malkasian GD Jr, Long HJ, Cha SS (1989) Endometrial stromal sarcoma: review of Mayo Clinic experience, 1945–1980. Gynecol Oncol 35:8–14CrossRefPubMedGoogle Scholar
  37. 37.
    Chu MC, Mor G, Lim C, Zheng W, Parkash V, Schwartz PE (2003) Low-grade endometrial stromal sarcoma: hormonal aspects. Gynecol Oncol 90:170–176CrossRefPubMedGoogle Scholar
  38. 38.
    Morice P, Rodrigues A, Pautier P et al (2003) Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure. Gynecol Obstet Fertil 31:147–150CrossRefPubMedGoogle Scholar
  39. 39.
    Menczer J, Levy T, Piura B et al (2005) A comparison between different postoperative treatment modalities of uterine carcinosarcoma. Gynecol Oncol 97:166–170CrossRefPubMedGoogle Scholar
  40. 40.
    Wu TI, Chang TC, Hsueh S et al (2006) Prognostic factors and impact of adjuvant chemotherapy for uterine leiomyosarcoma. Gynecol Oncol 100:166–172CrossRefPubMedGoogle Scholar
  41. 41.
    Tsikouras P, Liberis V, Galazios G, Savidis A, Grapsa A, Grapsas X, Teichmann AT, Maroulis G (2008) Uterine sarcoma: a report of 57 cases over a 16-year period analysis. Eur J Gynaecol Oncol 29(2):129–134PubMedGoogle Scholar
  42. 42.
    Giuntoli RL 2nd, Bristow RE (2004) Uterine leiomyosarcoma: present management. Curr Opin Oncol 16:324–327CrossRefPubMedGoogle Scholar
  43. 43.
    Goff BA, Rice LW, Fleischhacker D et al (1993) Uterine leiomyosarcoma and endometrial stromal sarcoma: lymph node metastases and sites of recurrence. Gynecol Oncol 50:105–109CrossRefPubMedGoogle Scholar
  44. 44.
    Gard GB, Mulvany NJ, Quinn MA (1999) Management of uterine leiomyosarcoma in Australia. Aust N Z J Obstet Gynaecol 39:93–98PubMedGoogle Scholar
  45. 45.
    Knocke TH, Kucera H, Dorfler D, Pokrajac B, Potter R (1998) Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer 83:1972–1979CrossRefPubMedGoogle Scholar
  46. 46.
    Livi L, Andreopoulou E, Shah N, Paiar F, Blake P, Judson I et al (2004) Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998. Clin Oncol 16:261–268CrossRefGoogle Scholar
  47. 47.
    Tore G, Toppuz E, Bilce N, Aslay I, Dincer M, Elgin A (1990) The role of adjuvant chemotherapy in the treatment of uterine sarcoma patients. Eur J Gynaecol Oncol 11:307–312PubMedGoogle Scholar
  48. 48.
    Nordal RR, Thoresen SO (1997) Uterine sarcomas in Norway 1956–1992: incidence, survival and mortality. Eur J Cancer 33:907–911CrossRefPubMedGoogle Scholar
  49. 49.
    Sutton G, Blessing JA, Malfetano JH (1996) Isofosfamide and doxorubicin in the treatment of advanced leiomyosarcoma of the uterus: a Gynecologic Oncologic Group study. Gynecol Oncol 62:226–229CrossRefPubMedGoogle Scholar
  50. 50.
    Lissoni A, Cormio G, Bonazzi C et al (1998) Fertility-sparing surgery in uterine leiomyosarcoma. Gynecol Oncol 70:348–350CrossRefPubMedGoogle Scholar
  51. 51.
    Bokhman JV, Yakovleva IA, Urmanchejeva AF (1990) Treatment of patients with sarcoma of the uterus. Eur J Gynaecol Oncol 11:225–231PubMedGoogle Scholar
  52. 52.
    Leitao MM, Sonoda Y, Brennan MF, Barakat RR, Chi DS (2003) Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol 91:209–212CrossRefPubMedGoogle Scholar
  53. 53.
    Larson B, Silfversward C, Nilsson B, Pettersson F (1990) Prognostic factors in uterine leiomyosarcoma. A clinical and histopathological study of 143 cases. The Radiumhemmet series 1936–1981. Acta Oncol 29:185–191CrossRefPubMedGoogle Scholar
  54. 54.
    Soh LT, Chew SH, Ang L (1999) Uterine leiomyosarcoma: a Singapore experience. Aust N Z J Obstet Gynaecol 39:246–248CrossRefPubMedGoogle Scholar
  55. 55.
    Nilsson PM, Nilsson E, Svanberg L, Samsioe G (2003) Longevity after early surgical menopause—the long-term effect of a permanent cessation of reproductive function and female sex hormone loss. Eur J Obstet Gynecol Reprod Biol 110:63–65CrossRefPubMedGoogle Scholar
  56. 56.
    Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS (2005) Ovarian conservation at the time of hysterectomy for benign disease. Obstet Gynecol 106:219–226PubMedGoogle Scholar
  57. 57.
    Kokawa K, Nishiyama K, Ikeuchi M, Ihara Y, Akamatsu N, Enomoto T et al (2006) Clinical outcomes of uterine sarcomas: results from 14 years worth of experience in the Kinki district in Japan (1990–2003). Int J Gynecol Cancer 16(3):1358–1363CrossRefPubMedGoogle Scholar
  58. 58.
    Sagae S, Yamashita K, Ishioka S, Nishioka Y, Terasawa K, Mori M et al (2004) Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan. Oncology 67(1):33–39CrossRefPubMedGoogle Scholar
  59. 59.
    Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A (2008) Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990–2001. Gynecol Oncol 111:74–81CrossRefPubMedGoogle Scholar
  60. 60.
    Fong Y, Coit DG, Woodruff JM, Brennan MF (1993) Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg 217:72–77CrossRefPubMedGoogle Scholar
  61. 61.
    Ariel IM (1988) Incidence of metastases to lymph nodes from soft-tissue sarcomas. Semin Surg Oncol 4:27–29CrossRefPubMedGoogle Scholar
  62. 62.
    Behranwala KA, A’Hern R, Omar AM, Thomas JM (2004) Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol 11:714–719CrossRefPubMedGoogle Scholar
  63. 63.
    Gaakeer HA, Albus-Lutter CE, Gortzak E, Zoetmulder FA (1988) Regional lymph node metastases in patients with soft tissue sarcomas of the extremities, what are the therapeutic consequences? Eur J Surg Oncol 14:151–156PubMedGoogle Scholar
  64. 64.
    Mazeron JJ, Suit HD (1987) Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer 60:1800–1808CrossRefPubMedGoogle Scholar
  65. 65.
    Ruka W, Emrich LJ, Driscoll DL, Karakousis CP (1988) Prognostic significance of lymph node metastasis and bone, major vessel, or nerve involvement in adults with high-grade soft tissue sarcomas. Cancer 62:999–1006CrossRefPubMedGoogle Scholar
  66. 66.
    Weingrad DN, Rosenberg SA (1978) Early lymphatic spread of osteogenic and soft-tissue sarcomas. Surgery 84:231–240PubMedGoogle Scholar
  67. 67.
    Ferrer R (1998) Lymphadenopathy: differential diagnosis and evaluation. Am Fam Physician 58:1313–1320PubMedGoogle Scholar
  68. 68.
    Ayhan A, Tuncer ZS, Tuncer R, Yuce K, Kucukali T (1995) Tumor status of lymph nodes in early endometrial cancer in relation to lymph node size. Eur J Obstet Gynecol Reprod Biol 60:61–63CrossRefPubMedGoogle Scholar
  69. 69.
    Tangjitgamol S, Manusirivithaya S, Jesadapatarakul S, Leelahakorn S, Thawaramara T (2006) Lymph node size in uterine cancer: a revisit. Int J Gynecol Cancer 16(5):1880–1884CrossRefPubMedGoogle Scholar
  70. 70.
    Girardi F, Petru E, Heydarfafadai M, Haas J, Winter R (1993) Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol 49:177–180CrossRefPubMedGoogle Scholar
  71. 71.
    Chuang L, Burke TW, Tornos C et al (1995) Staging laparotomy for endometrial carcinoma: assessment of retroperitoneal lymph nodes. Gynecol Oncol 58:189–193CrossRefPubMedGoogle Scholar
  72. 72.
    Reed NS (2008) The management of uterine sarcomas Clin Oncol 20(6):470–478Google Scholar
  73. 73.
    Temkin SM, Hellmann M, Lee YC, Abulafia O (2007) Early-stage carcinosarcoma of the uterus: the significance of lymph node count. Int J Gynecol Cancer 17(1):215–219CrossRefPubMedGoogle Scholar
  74. 74.
    Nemani D, Mitra N, Guo M, Lin L (2008) Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol 111:82–88CrossRefPubMedGoogle Scholar
  75. 75.
    Ali S, Wells M (1993) Mixed mullerian tumors of the uterine corpus: a review. Int J Gynecol Cancer 3:1–11CrossRefPubMedGoogle Scholar
  76. 76.
    Vaccarello L, Curtin JP (1992) Presentation and management of carcinosarcoma of the uterus. Oncology 6:45–49PubMedGoogle Scholar
  77. 77.
    Riopel J, Plante M, Renaud MC, Roy M, Tetu B (2005) Lymph node metastases in low-grade endometrial stromal sarcoma. Gynecol Oncol 96:402–406CrossRefPubMedGoogle Scholar
  78. 78.
    Reich O, Winter R, Regauer S (2005) Should lymphadenectomy be performed in patients with endometrial stromal sarcoma? Gynecol Oncol 97:982–983CrossRefPubMedGoogle Scholar
  79. 79.
    Amant F, De Knijf A, Van Calster B, Leunen K, Neven P, Berteloot P, Vergote I, Van Huffel S, Moerman P (2007) Clinical study investigating the role of lymphadenectomy, surgical castration and adjuvant hormonal treatment in endometrial stromal sarcoma. Br J Cancer 97(9):1194–1199CrossRefPubMedGoogle Scholar
  80. 80.
    Salazar OM, Bonfiglio TA, Patten SF, Keller BE, Feldsteim M, Dunne ME, Rudolph J (1978) Uterine sarcomas: natural history, treatment, and prognosis. Cancer 42:1152–1160CrossRefPubMedGoogle Scholar
  81. 81.
    Kahanpaa KV, Wahlstrom T, Grohn P, Heinonen E, Nieminen U, Widholm O (1986) Sarcomas of the uterus: a clinicopathologic study of 119 patients. Obstet Gynecol 67:417–424PubMedGoogle Scholar
  82. 82.
    Wheelock JB, Krebs HB, Schneider V, Goplerud DR (1985) Uterine sarcoma: analysis of prognostic variables in 71 cases. Am J Obstet Gynecol 151:1016–1022PubMedGoogle Scholar
  83. 83.
    Covens AL, Nisker JA, Chapman WB, Allen HH (1987) Uterine sarcoma: an analysis of 74 cases. Am J Obstet Gynecol 156:370–374PubMedGoogle Scholar
  84. 84.
    Omura GA, Major FJ, Blessing JA, Sedlacek TV, Thigpen JT, Creasman WT et al (1983) A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas. Cancer 52(4):626–632CrossRefPubMedGoogle Scholar
  85. 85.
    Giuntoli RL II, Garrett-Mayer E, Bristow RE, Gostout BS (2007) Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecol Oncol 106:82–88CrossRefPubMedGoogle Scholar
  86. 86.
    González-Bosquet E, Martínez-Palones JM, González-Bosquet J, García Jiménez A, Xercavins J (1997) Uterine sarcoma: a clinicopathological study of 93 cases. Eur J Gynaecol Oncol 18(3):192–195PubMedGoogle Scholar
  87. 87.
    Odunsi K, Moneke V, Tammela J et al (2004) Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up. Int J Gynecol Cancer 14:659–664CrossRefPubMedGoogle Scholar
  88. 88.
    Nola M, Babic D, Ilic J, Marusic M, Uzarevic B, Petrovecki M, Sabioncello A, Kovac D, Jukic S (1996) Prognostic parameters for survival of patients with malignant mesenchymal tumors of the uterus. Cancer 78:2543–2550CrossRefPubMedGoogle Scholar
  89. 89.
    Blom R, Guerrieri C, Stal O, Malmström H, Simonsen E (1998) Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases. Gynecol Oncol 68:54–61CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Alexandros Dafopoulos
    • 1
  • Panagiotis Tsikouras
    • 1
  • Marina Dimitraki
    • 1
  • Georgios Galazios
    • 1
  • Vasileios Liberis
    • 1
  • Georgios Maroulis
    • 1
  • Alexander Tobias Teichmann
    • 2
  1. 1.Department of Obstetrics and GynecologyUniversity Hospital of Alexandroupolis, Democritus University of ThraceAlexandroupolisGreece
  2. 2.Department of Obstetrics and GynecologyClinikum Aschaffenburg Teaching Hospital of Würzburg UniversityWürzburgGermany

Personalised recommendations